Sort by
Refine Your Search
-
in the Klein lab at Harvard Medical School in Boston Massachusetts. The work of the Klein lab is focused on revealing the molecular and environmental rules governing cell fate decisions in development
-
of their respective institutional cohort members. Further, the postdoctoral fellows will work to develop research objectives and future funding proposals for individual and joint research, with the assistance of Ethnos
-
the lives of American women of the past and present for the future, furthering the Institute's commitment to women, gender, and society. The Emerging Leaders Program is a youth leadership development program
-
on meiosis or with C. elegans is preferred. The successful candidate will work with Dr. Monica Colaiacovo to develop an independent research project within the scope of the lab’s research focus. In
-
. transformer models). One focus of this work will be on B-cell receptor evolution. Experience in applications of modern machine learning methods as well as in biological data analysis are needed for the position
-
fellow to join our studies on the genetic basis of human evolution, with a focus on the evolution of the human brain. Candidates with a strong track record in any biological field are welcome to apply
-
Postdoctoral Fellows to join our team. Our lab uses stem cell biology, immunology and genome engineering to unravel fundamental mechanisms of tissue regeneration and to develop new gene and cell therapies
-
facilities of the Harvard College Observatory and the Smithsonian Astrophysical Observatory under a single director to pursue studies of those basic physical processes that determine the nature and evolution
-
expertise through continuous engagement with scientific literature Mentor, or train less experienced team members or academic interns, as needed. Additional Information: We encourage candidates to apply by
-
and chemical biology. The lab aims to develop compounds that arrest cancer progression by chemical restoration of function to proteins that are inactivated by oncogenic mutations that drive cancer